+40.7%
THC vs AVAV
-68.0%
+108.7%
-34.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AVAV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +9.6% | -8.3% | +17.9% | +9.3% |
| 7D | +8.8% | -10.1% | +18.9% | +8.5% |
| 30D | +12.6% | -18.7% | +31.3% | +12.0% |
| 3M | +15.4% | -33.0% | +48.4% | +14.5% |
| 6M | +57.7% | -37.2% | +94.9% | +56.3% |
| YTD | +47.1% | -53.2% | +100.3% | +41.3% |
| 1Y | +40.7% | -69.0% | +109.7% | +48.5% |
| All | +40.7% | -68.0% | +108.7% | +48.5% |
Cumulative growth
Daily Returns
Daily percentage return beside AVAV.
Daily Out/Under-Performance
Portfolio return minus AVAV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AVAV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AVAV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling